Abstract
Nanosized artificial antigen-presenting cells (aAPCs), synthetic immune cell mimics that aim to activate T cells ex or in vivo, offer an effective alternative to cellular immunotherapies. However, comprehensive studies that delineate the effect of nano-aAPC topology, including nanoparticle morphology and ligand density, are lacking. Here, we systematically studied the topological effects of polymersome-based aAPCs on T cell activation. We employed an aAPC library created from biodegradable poly(ethylene glycol)-block-poly(d,l-lactide) (PEG-PDLLA) polymersomes with spherical or tubular shape and variable sizes, which were functionalized with αCD3 and αCD28 antibodies at controlled densities. Our results indicate that high ligand density leads to enhancement in T cell activation, which can be further augmented by employing polymersomes with larger size. At low ligand density, the effect of both polymersome shape and size was more pronounced, showing that large elongated polymersomes better activate T cells compared to their spherical or smaller counterparts. This study demonstrates the capacity of polymersomes as aAPCs and highlights the role of topology for their rational design.
| Original language | English |
|---|---|
| Pages (from-to) | 15072–15085 |
| Number of pages | 14 |
| Journal | ACS Nano |
| Volume | 16 |
| Issue number | 9 |
| Early online date | 15 Aug 2022 |
| DOIs | |
| Publication status | Published - 27 Sept 2022 |
Bibliographical note
Funding Information:A.C.W., L.K.E.A.A., and J.C.M.v.H. acknowledge support from the Dutch Ministry of Education, Culture and Science (Gravitation Program 024.001.035), the Spinoza premium, and the ERC Advanced Grant (Artisym 694120). J.T. is supported by an ERC Starting Grant (ImmunoCode 802791).
Funding
A.C.W., L.K.E.A.A., and J.C.M.v.H. acknowledge support from the Dutch Ministry of Education, Culture and Science (Gravitation Program 024.001.035), the Spinoza premium, and the ERC Advanced Grant (Artisym 694120). J.T. is supported by an ERC Starting Grant (ImmunoCode 802791).
| Funders | Funder number |
|---|---|
| European Union's Horizon 2020 - Research and Innovation Framework Programme | 802791, 694120 |
| European Union's Horizon 2020 - Research and Innovation Framework Programme | |
| Ministerie van Onderwijs, Cultuur en Wetenschap | 024.001.035 |
Keywords
- antibody density
- artificial antigen-presenting cells
- biodegradable polymersomes
- nano-immunotherapy
- nanoparticle morphology
- T cell activation
- Antigen-Presenting Cells
- Polyethylene Glycols
- Lymphocyte Activation
- Immunotherapy
- Ligands
Fingerprint
Dive into the research topics of 'Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation'. Together they form a unique fingerprint.Press/Media
-
Microbead Design for Enhanced CAR-T Manufacturing
van Hest, J. C. M. & Abdelmohsen, L. K. E. A.
4/05/23
1 item of Media coverage
Press/Media: Expert Comment
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver